Table 2.
All significant effects of Response Type (RT) and Valence (VA) in the global ERP analyses incorporating factors of Hemisphere (HM), Anterior/Posterior (AP), and Site (ST)
| 300–500 | 500–800 | 800–1400 | |
|---|---|---|---|
| Global: | |||
| RT | F (1.6, 26.8) = 5.49*, ηp 2 = 0.24 | F(1.4, 24.6) = 10.26**, ηp 2 = 0.38 | F(1.6, 27.2) = 4.11*, ηp 2 = 0.19 |
| VA | F(1, 17) = 18.45***, ηp 2 = 0.52 | F(1, 17) = 25.48***, ηp 2 = 0.60 | |
| RT × HM | F(1.3, 21.5) = 7.61**, ηp 2 = 0.31 | F(2.0, 33.9) = 4.02*, ηp 2 = 0.19 | |
| RT × ST | F(2.5, 41.8) = 3.95*, ηp 2 = 0.19 | ||
| VA × AP | F(1.4, 23.0) = 7.93**, ηp 2 = 0.31 | ||
| VA × ST | F(1.1, 19.2) = 5.93*, ηp 2 = 0.26 | F(1.1, 19.2) = 8.93**, ηp 2 = 0.34 | |
| RT × AP × HM | F(2.6, 44.0) = 4.51*, ηp 2 = 0.21 | F(3.0, 51.0) = 4.17**, ηp 2 = 0.20 | |
| RT × AP × ST | F(6.1, 104.5) = 2.49*, ηp 2 = 0.13 | F(5.4, 91.2) = 3.48**, ηp 2 = 0.17 | |
| VA × AP × HM | F(1.9, 33.0) = 4.30*, ηp 2 = 0.20 | ||
| VA × AP × ST | F(3.1, 53.2) = 5.04**, ηp 2 = 0.23 | F(4.1, 70.5) = 6.92***, ηp 2 = 0.29 | F(4.2, 71.9) = 3.90**, ηp 2 = 0.19 |
| VA × AP × HM × ST | F(3.7, 63.0) = 5.34***, ηp 2 = 0.24 | F(4.2, 71.2) = 4.70**, ηp 2 = 0.22 | F(3.9, 66.5) = 2.89*, ηp 2 = 0.15 |
| Target/New CR: | |||
| RT | F(1, 17) = 9.11**, ηp 2 = 0.35 | F(1, 17) = 17.53**, ηp 2 = 0.51 | |
| VA | F(1, 17) = 12.44**, ηp 2 = 0.42 | F(1, 17) = 14.05**, ηp 2 = 0.45 | |
| RT × HM | F(1, 17) = 7.61*, ηp 2 = 0.31 | ||
| RT × ST | F(2.0, 34.6) = 4.55*, ηp 2 = 0.21 | F(2.2, 37.3) = 10.99***, ηp 2 = 0.39 | |
| VA × HM | F(1, 17) = 5.69*, ηp 2 = 0.25 | ||
| VA × ST | F(1.3, 21.8) = 5.30*, ηp 2 = 0.24 | F(1.2, 20.5) = 6.37*, ηp 2 = 0.27 | |
| RT × AP × HM | F(2.0, 33.6) = 9.88***, ηp 2 = 0.37 | F(1.9, 32.9) = 6.44**, ηp 2 = 0.27 | |
| RT × AP × ST | F(3.4, 58.5) = 4.00**, ηp 2 = 0.19 | ||
| VA × AP × ST | F(2.8, 47.6) = 4.00*, ηp 2 = 0.19 | F(4.4, 74.7) = 4.81**, ηp 2 = 0.22 | F(4.5, 76.3) = 2.88*, ηp 2 = 0.14 |
| VA × AP × HM × ST | F(3.7, 62.4) = 5.38**, ηp 2 = 0.24 | F(3.6,61.3) = 3.98**, ηp 2 = 0.19 | |
| Nontarget/New CR: | |||
| RT | F(1, 17) = 4.51*, ηp 2 = 0.21 | ||
| VA | F(1, 17) = 20.73***, ηp 2 = 0.55 | F(1, 17) = 31.71***, ηp 2 = 0.65 | F(1, 17) = 9.01**, ηp 2 = 0.35 |
| RT × HM | F(1, 17) = 7.14*, ηp 2 = 0.30 | ||
| RT × ST | F(1.2, 21.2) = 4.07*, ηp 2 = 0.19 | F(1, 17) = 8.60**, ηp 2 = 0.36 | |
| VA × AP | F(1.3, 21.7) = 7.57**, ηp 2 = 0.31 | F(1.2, 20.2) = 4.27*, ηp 2 = 0.20 | |
| VA × ST | F(1.2, 19.8) = 4.85*, ηp 2 = 0.22 | F(1.2, 19.7) = 6.40*, ηp 2 = 0.27 | |
| RT × VA × HM | F(1, 17) = 6.66*, ηp 2 = 0.28 | ||
| RT × AP × HM | F(1.5, 25.5) = 7.39**, ηp 2 = 0.30 | F(1.8, 31.0) = 8.24**, ηp 2 = 0.33 | |
| RT × AP × ST | F(4.2, 71.0) = 3.15*, ηp 2 = 0.16 | F(3.6, 61.6) = 5.07**, ηp 2 = 0.23 | |
| VA × AP × HM | F(1.8, 30.5) = 4.29*, ηp 2 = 0.20 | ||
| VA × AP × ST | F(4.1, 69.9) = 5.28**, ηp 2 = 0.24 | F(3.9, 65.8) = 2.75*, ηp 2 = 0.14 | |
| VA × AP × HM × ST | F(3.7, 63.6) = 4.42**, ηp 2 = 0.21 | ||
| RT × VA × HM × ST | F(2.4, 40.0) = 3.50*, ηp 2 = 0.17 | ||
| Target/Nontarget: | |||
| RT | F(1, 17) = 28.27***, ηp 2 = .062 | F(1, 17) = 13.51**, ηp 2 = 0.44 | |
| VA | F(1, 17) = 10.77**, ηp 2 = 0.39 | F(1, 17) = 16.19**, ηp 2 = 0.49 | |
| VA × AP | F(1.3, 21.6) = 5.84*, ηp 2 = 0.26 | ||
| VA × ST | F(1.2, 20.4) = 6.92**, ηp 2 = 0.29 | ||
| VA × AP × ST | F(3.6, 61.0) = 3.51*, ηp 2 = 0.17 | F(3.9, 66.8) = 4.05**, ηp 2 = 0.19 | F(4.1, 70.5) = 2.91*, ηp 2 = 0.15 |
| VA × AP × HM × ST | F(3.9, 65.8) = 3.30*, ηp 2 = 0.16 | F(4.0, 68.7) = 3.63**, ηp 2 = 0.18 | F(3.9, 65.5) = 2.75*, ηp 2 = 0.14 |
*p < .5. **p < .01. ***p < .001